Oppenheimer Asset Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $424K | Buy |
3,884
+614
| +19% | +$58.5K | ﹤0.01% | 900 |
|
|
2025
Q4 | $265K | Sell |
3,270
-397
| -11% | -$34.2K | ﹤0.01% | 939 |
|
|
2025
Q3 | $321K | Sell |
3,667
-89
| -2% | -$7.95K | ﹤0.01% | 997 |
|
|
2025
Q2 | $312K | Sell |
3,756
-32
| -0.8% | -$2.67K | ﹤0.01% | 978 |
|
|
2025
Q1 | $318K | Sell |
3,788
-332
| -8% | -$30.9K | ﹤0.01% | 952 |
|
|
2024
Q4 | $380K | Sell |
4,120
-1,651
| -29% | -$159K | ﹤0.01% | 934 |
|
|
2024
Q3 | $536K | Sell |
5,771
-6,601
| -53% | -$572K | 0.01% | 863 |
|
|
2024
Q2 | $1.02M | Buy |
12,372
+1,767
| +17% | +$130K | 0.01% | 708 |
|
|
2024
Q1 | $704K | Sell |
10,605
-2,803
| -21% | -$173K | 0.01% | 764 |
|
|
2023
Q4 | $761K | Buy |
13,408
+7,647
| +133% | +$401K | 0.01% | 773 |
|
|
2023
Q3 | $314K | Sell |
5,761
-2,735
| -32% | -$162K | ﹤0.01% | 957 |
|
|
2023
Q2 | $572K | Sell |
8,496
-5,184
| -38% | -$316K | 0.01% | 833 |
|
|
2023
Q1 | $704K | Buy |
13,680
+1,661
| +14% | +$80.6K | 0.01% | 765 |
|
|
2022
Q4 | $553K | Buy |
12,019
+4,057
| +51% | +$190K | 0.01% | 828 |
|
|
2022
Q3 | $404K | Sell |
7,962
-222
| -3% | -$11.1K | 0.01% | 882 |
|
|
2022
Q2 | $373K | Buy |
8,184
+134
| +2% | +$5.99K | 0.01% | 927 |
|
|
2022
Q1 | $374K | Buy |
8,050
+560
| +7% | +$25.1K | 0.01% | 979 |
|
|
2021
Q4 | $376K | Sell |
7,490
-116
| -2% | -$6K | 0.01% | 1027 |
|
|
2021
Q3 | $404K | Sell |
7,606
-2,225
| -23% | -$125K | 0.01% | 982 |
|
|
2021
Q2 | $600K | Buy |
9,831
+137
| +1% | +$7.28K | 0.01% | 900 |
|
|
2021
Q1 | $473K | Buy |
9,694
+855
| +10% | +$40.1K | 0.01% | 927 |
|
|
2020
Q4 | $358K | Buy |
8,839
+916
| +12% | +$32.7K | 0.01% | 958 |
|
|
2020
Q3 | $258K | Sell |
7,923
-318
| -4% | -$9.55K | 0.01% | 973 |
|
|
2020
Q2 | $218K | Buy |
8,241
+973
| +13% | +$25.4K | ﹤0.01% | 1000 |
|
|
2020
Q1 | $182K | Buy |
7,268
+7,038
| +3,060% | +$217K | ﹤0.01% | 989 |
|
|
2019
Q4 | $8K | Hold |
230
| – | – | ﹤0.01% | 1514 |
|
|
2019
Q3 | $8K | Hold |
230
| – | – | ﹤0.01% | 1512 |
|
|
2019
Q2 | $6K | Hold |
230
| – | – | ﹤0.01% | 1546 |
|
|
2019
Q1 | $7K | Hold |
230
| – | – | ﹤0.01% | 1511 |
|
|
2018
Q4 | $5K | Buy |
+230
| New | +$6.28K | ﹤0.01% | 1554 |
|
|
2018
Q2 | – | Sell |
-6,056
| Closed | -$219K | – | 1164 |
|
|
2018
Q1 | $219K | Sell |
6,056
-257
| -4% | -$8.9K | 0.01% | 1037 |
|
|
2017
Q4 | $236K | Hold |
6,313
| – | – | 0.01% | 1001 |
|
|
2017
Q3 | $236K | Sell |
6,313
-42
| -0.7% | -$1.43K | 0.01% | 1006 |
|
|
2017
Q2 | $198K | Buy |
6,355
+6,224
| +4,751% | +$180K | 0.01% | 1040 |
|
|
2017
Q1 | $3K | Buy |
+131
| New | +$3.08K | ﹤0.01% | 1620 |
|
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
Oppenheimer Asset Management's LMAT Position: Q1 2026 in Review
Oppenheimer Asset Management increased its LeMaitre Vascular (LMAT) stake by 19% in Q1 2026, buying an estimated $58.5K and bringing the position to 3,884 shares worth $424K. The position accounts for ﹤0.01% of the portfolio, ranked #900.
Oppenheimer Asset Management first reported a position in LMAT in Q1 2017 and has held it in 35 quarters since. The position peaked at $1.02M in Q2 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- Oppenheimer Asset Management held 3,884 shares of LeMaitre Vascular worth $424K as of Q1 2026.
- Oppenheimer Asset Management bought 614 LeMaitre Vascular shares in Q1 2026, an estimated $58.5K.
- LeMaitre Vascular made up ﹤0.01% of Oppenheimer Asset Management's portfolio in Q1 2026, its #900 holding.
- Oppenheimer Asset Management first reported a position in LeMaitre Vascular in Q1 2017 and has held it in 35 quarters since.
- Oppenheimer Asset Management's LeMaitre Vascular position peaked at $1.02M in Q2 2024.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on Oppenheimer Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.